367 related articles for article (PubMed ID: 21752736)
1. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms.
Bretagne JF; Honnorat C; Richard-Molard B; Caekaert A; Barthélemy P
Aliment Pharmacol Ther; 2006 Mar; 23(5):607-16. PubMed ID: 16480400
[TBL] [Abstract][Full Text] [Related]
3. Sleep dysfunction in patients with gastro-oesophageal reflux disease: prevalence and response to GERD therapy, a pilot study.
Chand N; Johnson DA; Tabangin M; Ware JC
Aliment Pharmacol Ther; 2004 Nov; 20(9):969-74. PubMed ID: 15521844
[TBL] [Abstract][Full Text] [Related]
4. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
Pace F; Bollani S; Molteni P; Bianchi Porro G
Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study.
Jaspersen D; Labenz J; Willich SN; Kulig M; Nocon M; Leodolter A; Lind T; Meyer-Sabellek W; Vieth M; Stolte M; Malfertheiner P
Dig Liver Dis; 2006 Apr; 38(4):233-8. PubMed ID: 16413233
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic gastro-oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea.
Guda N; Partington S; Vakil N
Aliment Pharmacol Ther; 2004 Nov; 20(10):1153-9. PubMed ID: 15569118
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: a nationwide population-based study.
Chiocca JC; Olmos JA; Salis GB; Soifer LO; Higa R; Marcolongo M;
Aliment Pharmacol Ther; 2005 Aug; 22(4):331-42. PubMed ID: 16098000
[TBL] [Abstract][Full Text] [Related]
8. Gastro-oesophageal reflux symptoms are related to the presence and severity of obstructive sleep apnoea.
Shepherd KL; James AL; Musk AW; Hunter ML; Hillman DR; Eastwood PR
J Sleep Res; 2011 Mar; 20(1 Pt 2):241-9. PubMed ID: 20545839
[TBL] [Abstract][Full Text] [Related]
9. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
[TBL] [Abstract][Full Text] [Related]
10. Routine management of gastro-oesophageal reflux disease by gastroenterologists in France: a prospective observational study.
Bretagne JF; Rey JF; Caekaert A; Barthélemy P
Dig Liver Dis; 2005 Aug; 37(8):566-70. PubMed ID: 15886080
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
12. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care.
Jones R; Coyne K; Wiklund I
Aliment Pharmacol Ther; 2007 Jun; 25(12):1451-9. PubMed ID: 17539985
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840
[TBL] [Abstract][Full Text] [Related]
14. New algorithm for the treatment of gastro-oesophageal reflux disease.
Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
[TBL] [Abstract][Full Text] [Related]
15. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for gastro-oesophageal reflux disease symptoms: a community study.
Mohammed I; Nightingale P; Trudgill NJ
Aliment Pharmacol Ther; 2005 Apr; 21(7):821-7. PubMed ID: 15801917
[TBL] [Abstract][Full Text] [Related]
17. Gastro-oesophageal reflux disease--impact of guidelines on GP management.
Kirby CN; Piterman L; Nelson MR; Dent J
Aust Fam Physician; 2008; 37(1-2):73-7. PubMed ID: 18239758
[TBL] [Abstract][Full Text] [Related]
18. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
[TBL] [Abstract][Full Text] [Related]
19. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
Juul-Hansen P; Rydning A
Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Baron A; Smout AJ
Aliment Pharmacol Ther; 2006 Nov; 24(9):1377-84. PubMed ID: 17059519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
